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Background: The aim of our study was to evaluate the effect of programmed 
physical activity and a single exercise test on the number of CD309+ circulating 
endothelial progenitor cell (EPC) and their relation to the variation in plasma 
levels of VEGF in chronic coronary patients. 
Methods: 21 patients <75 years with chronic stable coronary artery disease 
were included. All patients underwent exercise myocardial perfusion SPECT. 
Then, participants were divided into two groups: one group (11 patients) 
underwent cardiac rehabilitation program and the other (10 patients) continued 
with the standard treatment. Blood samples were obtained at baseline, 30 
minutes after exercise ended and at one and three months during follow-up. 
Results: VEGF values decreased significantly after exercise SPECT test. After 
one month, there was a significant increase in VEGF levels compared to those 
measured immediately after exercise. All patients showed a decrease in the 
values of EPC at 1 and 3-month follow-up. There was an inverse and 
statistically significant relation between change of EPC and VEGF between the 
baseline and 1 month.  
Conclusions: The increase of VEGF at 1-month, with respect to baseline 
values correlated with decreased levels of EPC. This association was 
independent of the onset of ischemia in the perfusion study. 
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The programmed exercise is a very important tool complementary to medical 
treatment and myocardial revascularization in patients with chronic coronary 
disease. 
One of the proposed mechanisms of action, is that physical activity promotes 
angiogenesis by increasing the levels and/or half-life of vascular endothelial 
growth factor (VEGF). Furthermore ischemia is a major stimuli for VEGF 
production and for local enhancements of its effects.[1, 2] 
It has also been established that endothelial progenitor cells (EPC) 
characterized by coexpression of Sca-1 receptor 2 of VEGF or VEGF-2 or KDR 
[3] improve angiogenesis, promote vascular repair, improve endothelial 
function, inhibit atherosclerosis and increase the ventricular function after 
myocardial infarction. 
Physical training appear to be the most effective intervention to stimulate EPC 
[4] in both healthy subjects and patients with coronary disease. [5-7] 
Exercise increases the production and the number of EPCs in patients with 
coronary disease and this increase would be time-dependent after a single 
episode of exercise-induced ischemia. [7-9] 
However, extreme exercise such as marathon running, seems to decrease the 
number of circulating EPC defined with CD34+ or CD133+ after the race and 
even after several days[10, 11], while the total number of EPC remains 















The increase in the number and migratory activity generated by exercise could 
be mediated by an upregulation of NO and VEGF as much as by a reduction in 
apoptosis of EPC.[6] 
It has been shown that VEGF is one of the most potent stimuli for the release of 
EPC. [12, 13] VEGF would activate metalloproteinase-9 (MMP-9), which 
stimulates stem cells to migrate from a quiescent bone marrow niche to the 
vascular site. [14] The peak of the increase of VEGF clearly precedes the rising 
levels of EPC. [15] Furthermore, the antigen CD309 is a high affinity receptor 
for VEGF and plays an important role in hematopoiesis and is also involved in 
angiogenesis, in embryogenesis and in the context of homeostatic and 
pathological events. CD309-VEGFR-2 has been identified in subsets of 
hematopoietic stem cells, EPC and mature endothelial cells.  
Therefore, the goal of the study was to evaluate in chronic coronary patients, 
the effect of acute exercise (as the stress test) on EPC and VEGF and its 
relationships according to the presence of ischemia. A second goal was to 
study in these patients, the effects of chronic exercise (as rehabilitation 
















This study included 21 patients, < 75 years, with chronic stable coronary artery 
disease documented by coronary angiography, previous infarction or perfusion 
tests positive for ischemia performed more than 6 months ago. They should not 
have participated in groups of programmed physical activity within the last 3 
months. 
Patients unable to perform physical activity, or with extracardiac conditions 
affecting survival, associated cardiomyopathies or valvular heart disease, 
severe ventricular arrhythmia, heart failure, uncontrolled hypertension, FC III-IV 
angina despite treatment or a positive high-risk exercise stress test were 
excluded. All patients gave written informed consent to the study protocol, 
which was approved by the ethical committee. 
After baseline evaluation, all the patients underwent exercise stress myocardial 
perfusion SPECT. According to the test results, two groups were defined:  
 Patients with normal perfusion test. 
 Patients with positive perfusion test defined by the presence of exercise-
induced myocardial ischemia. 
Then, the patients were randomly assigned to two groups:  
 Patients not undergoing programmed physical activity (control group) (10 
patients). 
 Patients undergoing rehabilitation program with three exercise bouts weekly 















Aggravation of symptoms, manifestation of events or development of physical 
disability to continue with the exercise were considered causes of exclusion 
during follow-up. 
Determination of VEGF 
Blood samples were obtained at baseline, 30 minutes after exercise, and at one 
and three months during follow-up by vein puncture in tubes containing 
ethylenediaminetetraacetic acid tripotassium salt (K3EDTA) and stored at -70°. 
Determination of VEGF was performed using Quantikine Human VEGF 
Immunoassay (R&D, catalog # DVE00) that employs the quantitative sandwich 
enzyme immunoassay technique with a monoclonal antibody specific for VEGF. 
This technique allows determination of VEGF in a range from 15.6 to 1000 
pg/mL. The intra-assay precision and inter-assay precision are 5% and 8%, 
respectively.  
Determination of EPC 
Venous blood samples were collected in tubes containing K3EDTA and 
preserved at room temperature until they were processed. 
Samples were incubated with lysis solution at room temperature for 20 minutes 
(2 ml of blood with anticoagulant in 14 ml of lysis liquid), then they were 
centrifuged (300xg, 10 minutes), the supernatant was discarded, and the cell 
button was resuspended in PBS. This procedure was repeated twice in order to 
obtain a purified erythrocyte-free population of cells.  
Sixty μl of cells were incubated with 20 μl of FcR at room temperature during 15 
minutes. Then they were washed and resuspended in 4 aliquots of 100 μl each: 















Aliquot 2: CD45-FITC + Mouse IgG1-PE 
Aliquot 3: CD45-FITC + CD34-PE 
Aliquot 4: CD34-PE + CD309-PE 
All aliquots were incubated in the dark during 40 minutes, and afterwards they 
were diluted with 450 μl of Isoflow and passed through the cytometer. 
The samples were acquired on FACSCan -Becton Dickinson equipped with an 
Argon laser operated at 488 nm and analyzed by flow cytometer with CellQuest 
software.  
CD45-FITC/anti-IgG-PE was used in aliquot 2 to compensate and delimit the 
CD45+ region used for further acquisitions. So red cells, platelets and cells 
debris were excluded from analysis. 
Region 1 (R1) was obtained from double positivity quadrant (CD34+/CD45+), we 
took into account cells that also expressed CD34+ from all mononuclear cells 
(CD45+) (aliquot 3).  
Samples of aliquot 4 were acquired to inform the expression of double positivity, 
and analyzed CD34+/CD309+, using R1 pre-labeled with aliquot 3. CD34 cells 
that coexpress CD309 support the existence of ECPs.  
The amount of ECP is expressed as mean ± standard error (SEM) /100000 
events. The events represent the passage of cells by laser equipment. 
Myocardial perfusion test 
Stress-rest SPECT imaging with 99mTc-sestamibi was performed within the 















A cycle ergometer was used for exercise stress test following the Bruce protocol 
under vital signs control and electrocardiographic monitoring. The test was 
stopped according to conventional criteria. 
The radioisotope was injected at rest and at peak exercise. Images were 
obtained 30 and 60 minutes after each injection of the radioisotope, using a 
step and shoot method in 64 projections. Rest and stress images were acquired 
in the short-axis view and horizontal and vertical long-axis views. The images 
were interpreted using a 17-segment heart model. A grading scale of 0 to 4 was 
used to score perfusion in each segment, where 0 = normal perfusion, 1 = mild 
hypoperfusion, 2 = moderate hypoperfusion, 3 = severe hypoperfusion, and 4 = 
absence of perfusion. The sum of the perfusion defects at rest and during stress 
constituted the summed rest score (SRS) and the summed stress scores (SSS). 
The summed difference score (SDS) or ischemia was calculated by subtracting 
the SRS from the SSS. A SDS ≥ 2 was considered positive for ischemia.  
Cardiac rehabilitation program 
Physical activity was performed twice a week in a rehabilitation center and once 
a week at the patient's home. During this period the patients continued with 
their regular anti-ischemic medication. 
Rehabilitation plan consisted in calisthenics, biking with and without workload, 
gym or recreational activity, and long walks especially designed for each 
patient. 
Statistical analysis 
Categorical variables are presented as frequencies with the corresponding 















the mean (SEM) and median (interquartile range) according to the data 
distribution. The distribution of quantitative variables was established by 
analyzing the asymmetry (skewness) and kurtosis, and the Shapiro-Wilk test. 
Discrete variables were analyzed with the chi-square test or Fisher's exact test, 
as applicable. 
For continuous variables, t test for two independent samples or Kruskal-Wallis 
test after verification of the homogeneity of variance with Bartlett's test. A paired 
t test was used to compare intragroup differences of continuous variables.  
For the analysis of the relationship between VEGF and EPC values and its 


















Twenty-one patients were included; mean age was 62.5 ± 1.7 years. Seventeen 
patients were male (81.0%). Baseline characteristics are summarized in Table 
1. 
Ischemia was present in 9 patients with median SDS of 4 (2-6). There were no 
differences in the result of the exercise test according to the presence of 
ischemia in SPECT. The maximal heart rate during stress test was 120,3 ± 5.4 
bpm in patients with ischemia and 119.3 ± 4.8 bpm in patients without ischemia 
(p=0.89). The maximal double-product was 20373 ± 1002 and 20422 ± 1487 
respectively (p=0.89).  
10 patients were assigned to programmed physical activity (6 had ischemia in 
SPECT) and 11 patients continued with standard treatment (control group) (4 
with ischemia in SPECT). 
Results of the measurement of EPC are summarized in Table 2. No differences 
between baseline and immediately after exercise were observed, either by the 
presence of ischemia in perfusion study or not. 
All patients showed a decrease in the values of EPC at 1 and 3-month follow-up 
regardless of programmed physical activity. 
The results of VEGF levels are summarized on Table 3. VEGF values 
decreased significantly after exercise SPECT test (49.49 ± 6.06 pg/mL vs. 
31.83 ± 5.62 pg/mL; p=0.021). After one month, there was a significant increase 
in VEGF levels compared to those measured immediately after exercise (70.90 
















At 3 months, VEGF values presented a non-significant increase compared to 
baseline values (p = 0.12) and were similar to the levels measured after one 
month.  
Based on the presence of ischemia in myocardial perfusion, the results were 
similar to those of the general population. There was no relationship between 
changes in the VEGF and the degree of ischemia observed in SPECT. 
No statistically significant differences were observed in the follow-up at 1 and 3 
months in patients who underwent programmed physical exercises. 
No differences according to the presence of ischemia in patients in the control 
group and rehabilitation group were observed (Table 3). 
There was a moderate positive correlation between baseline EPC CD309+ and 
VEGF (r = 0.44; p = 0.047). This relationship was more significant in patients 
without ischemia in perfusion study (Table 4). 
Considering the variation of EPC and VEGF with the "acute" (basal - post-effort) 
exercise globally, we observed that there was no relationship between them. 
By correlating the delta of EPC and VEGF between the baseline sample and 
values at 1 month, it was inverse and statistically significant (ΔCD309+ / 
ΔVEGF: r = -0.57; p = 0.007) (figure 1). 
A significant correlation was also observed in the variation of the values of EPC 
and VEGF between pos-exercise test and 1-month (ΔCD309+ / ΔVEGF: r = -
0.59; p = 0.005). 
These results were similar in both patients with and without ischemia, and in the 
















An increase of EPC values was observed at 3-month follow-up (compared with 
















In this study we evaluated the effect of programmed physical activity and a 
single exercise test on the number of CD309+ EPC and their relation to the 
variation in plasma levels of VEGF in chronic coronary patients. We did not 
observe a significant change in EPC levels with acute exercise. At 1-month 
there was a decrease in EPC in all patients (more marked in patients who 
performed programmed exercises). In the third month, EPC levels recovered to 
even exceeding baseline levels in the exercise group patients, although without 
statistical significance. 
VEGF values decreased significantly with acute exercise. At 1-month follow-up 
there was a not statistically significant increase compared to baseline. 
We did not observe a clear relationship between the change of VEGF and EPC 
between baseline and immediately after exercise test. 
Although we detected a significant direct (but moderate) relationship between 
baseline VEGF and CD309+ cells levels, it was mostly at the expense of 
patients with ischemia in perfusion study, suggesting that ischemia act as a 
trigger of both or have relation with baseline levels. 
However, despite the decline of VEGF, there was no significant variation in 
levels of EPC with acute exercise. 
Our results are different from those observed by Danzig et al [16] that evaluated 
the levels of VEGF and MMP-9 before and after exercise in patients with 
coronary disease and performed an exercise stress test. In this study, no 















observed nor after exercise test, although there was a non-significant decrease 
in VEGF levels in patients with coronary artery disease). 
The absence of variation of VEGF would be in accordance with the fact that 
exercise positively influences angiogenesis, which anyway is not directly 
determined by the VEGF elevation but by influencing the VEGF rate and the 
antiangiogenic protein, endostatin. [16] 
Silva et al [17] showed in a systematic review that in healthy subjects, most 
studies evaluating a single session of maximum exercise observed no 
significant changes in plasma levels of VEGF.[8, 18, 19] 
After a single session of exercise on a cycle-ergometer at 70% of the anaerobic 
threshold, the plasma levels of VEGF significantly increased only after 10 
minutes of exercise with a significant correlation with the number of cells 
CD133+/KDR+.[20] 
However, Adam et al [11] showed a decrease in plasma levels of VEGF after a 
marathon without correlation with the number of CD34+/VEGFR-2+ cells. 
Higher plasma levels of VEGF were verified after periods of long / ultra long 
lasting exercises.[17] These would be associated with the presence of tissue 
hypoxia in these conditions, which favor the stimulus for EPC mobilization and 
endothelial repair.[17] 
Increased VEGF levels would be a physiological adaptation of exercise and 
suggests a positive correlation between exercise intensity and the release of 
growth factors.[21] Thus, it would stimulate gene expression of EPC mobilizing 
molecules such as VEGF, which is in line with our observed increase of VEGF 















The increase of VEGF at 1-month was correlated with decreased levels of EPC, 
which could mean higher incorporation of cells into tissues and therefore a 
lower circulating levels. This relationship was observed independently of the 
occurrence of ischemia in perfusion study. 
At 3 months, values of EPC increased unrelated to the variation of VEGF so 
other mechanisms not studied in this protocol could be involved. Longer and/or 
more intense periods of training may be necessary to spell them out. 
The discrepancies observed with previous studies may be due to different cell 
types studied, the period of time between exercise and blood collection, and the 
intensity and duration of exercises, both in "acute" exercise and "chronic" 
exercise. 
The mobilization of progenitor cells, which is NO dependent,[22] could be 
improved by higher metabolic stress. However, this effect is relatively short and 
is not apparent after 48 hours post-exercise. Likewise, obtaining blood samples 
24-48 hours after completing the rehabilitation program sessions might have 
influenced our results. 
A limitation could be that most patients with chronic coronary artery disease 
who meet the inclusion criteria were men but the gender distribution is, in the 
population of our hospital, similar to that included in the study. Mobilization of 
progenitor cells could also be depending on exercise intensity suggesting a 
physiological stimulus to improve oxygen delivery via increased capillary 
network in the exercise above anaerobic threshold. In addition there are several 















tissues, which may have the potential to differentiate into endothelial blood 
cells, so that this variation may also contribute to the discrepancy in the results. 
Conclusion 
The increase of VEGF at 1-month, with respect to baseline values correlated 
with decreased levels of EPC, which could mean higher incorporation of cells 
into tissues and therefore a lower level of circulating cells. This association was 
independent of the onset of ischemia in the perfusion study. No relationship with 















Table 1. Clinical Characteristics of the Study Patients 
 
Variables Study Population Control Group Exercise Group p 
n 21 11 10  
Age (years) (mean ± SEM) 62.5 ± 1.7 65.4 ± 1.6 59.5 ± 2.8 0.08 
 n % n % n %  
Male gender 17 81.0 10 90.9 7 70.0 0.25 
Coronary Risk Factors        
Hypertension 17 81.0 10 90.9 7 70.0 0.25 
Dyslipidemia 14 66.7 6 54.4 8 80.0 0.22 
Diabetes mellitus 2 9.5 2 18.2 0  0.26 
Current smoker 2 9.5 1 9.1 1 10.0 0.74 
Ex-smoker 10 47.6 6 54.4 4 40.0 0.41 
Obesity 8 38.1 4 36.4 4 40.0 0.61 
Coronary History        
Chronic stable angina 16 76.2 8 72.7 8 80.0 0.55 
FC I 5 31.3 2 25.0 3 37.5  
FC II 11 68.8 6 75.0 5 62.5 0.50 
Myocardial infarction 8 38.1 5 45.5 3 30.0 0.39 
Angioplasty 7 33.3 3 27.3 4 40.0 0.44 
CABG 2 9.5 1 9.1 1 10 0.74 
Medical treatment        
Aspirin 20 95.2 10 90.9 10 100 0.52 















Nitrates 7 33.3 4 36.4 3 30.0 0.56 
Calcium-blockers 3 14.3 2 18.2 1 10.0 0.54 
Converting Enzyme Inhibitors / 
AT II Blockers 
13 61.9 6 54.5 7 70.0 0.39 

















Table 2. Measurement of endothelial progenitor cells (CD309+) in the study 
population and in the subgroups according to presence or absence of ischemia 





Month 1 Month 3 
Mean 0.166 0.149 0.044 * 0.091 ** *** 
SEM 0.030 0.025 0.004 0.008 
 Without Ischemia 
(n=12) 
Mean  0.254 0.132 0.039 0.088 
SEM 0.025 0.020 0.003 0.009 
 Ischemia  
(n=9) 
Mean 0.206 0.184 0.035 0.102 
SEM 0.071 0.059 0.004 0.017 
 Control Group 
(n=11) 
Mean 0.208  0.041 0.088 
SEM 0.060  0.003 0.013 
 Exercise Group 
(n=10) 
Mean 0.141  0.033 0.101 

















SEM, standard error of mean. 



















Table 3. VEGF levels in the study population and in the subgroups according to 





Month 1 Month 3 
Mean 49.59 31.83 * 70.90 **  *** 67.48 
SEM 6.06 5.62 14.44 13.31 
 Without Ischemia 
(n=12) 
Mean 46.69 34.29 * 78.71 **** 63.25 
SEM 6.78 9.60 22.07 17.14 
 Ischemia  
(n=9) 
Mean 53.44 28.56 ***** 60.50 ****** 73.11 
SEM 11.26 3.65 17.35 22.11 
 Basal  Mes 1 Mes 3 
 Control Group 
(n=11) 
Mean 45.25  82.41 60.68 ** 
SEM 9.24  26.68 17.87 
 Exercise Group 
(n=10) 
Mean 54.35  58.25  74.95 















SEM, standar error of mean 
* p=0.021 vs. Baseline; ** p=0.007 vs. After exercise test; *** p=0.10 vs. 
Baseline.  
**** p=0.05 vs. After exercise test; ***** p=0.057 vs. Baseline; ****** p=0.07 vs. 






















 r p r p r p r p r p 




0.15 0.52 0.60 0.08 0.08 0.81     
Month 1 0.14 0.55 -0.23 0.95 0.21 9.52 0.56 0.12 0.01 0.97 
Month 3 0.13 0.58 -0.23 0.95 -0.05 0.23 -0.03 0.93 0.24 0.45 


















































Figure 1. Correlatiof the delta of EPC and delta of VEGF between the baseline 
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1. VEGF values decrease after acute exercise and significantly increase after 1 
month 
2. CD309 endothelial cells decrease after 1 and 3 months independently of 
exercise 
3. An inverse relation between change of EPC and VEGF at 1 month was observed 
4. These associations were independent of the presence of ischemia or type of 
exercise 
